Artemether–lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study

Artemether–lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study

Abstract Background Ethiopia has set a goal to eliminate malaria by 2030; Artemether–lumefantrine (AL) is put as one of the cornerstone strategies for uncomplicated plasmodium falciparum malaria treatment. However, only focusing on prescribing of the treatment without assessing patients’ adherence c...

Full description

Bibliographic Details
Main Authors: Mekonnen Gebremichael Gebrekidan, Gebretsadik Berhe Gebremedhin, Yosef Sibhatu Gebregiorgis, Alefech Addisu Gezehegn, Kissanet Tesfay Weldearegay
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Antimicrobial Resistance and Infection Control
Subjects:
Artemether–lumefantrine
Adherence
Plasmodium falciparum
Online Access:http://link.springer.com/article/10.1186/s13756-020-00846-y

Internet

http://link.springer.com/article/10.1186/s13756-020-00846-y

Similar Items